Organizations Ask People with HIV be Included in Vaccine Research
IDSA, HIVMA request they be included in ongoing COVID-19 clinical trials.
How Are Vaccines Deemed Safe?
A discussion on the process by which the FDA regulates vaccine candidates at a time when COVID-19 candidates are progressing.
The COVID-19 Live Vaccine Tracker
Here is a compilation of the COVID-19 vaccine candidates that have achieved FDA Emergency Use Authorization, other approvals, and are in phases 1-3.
Dual Anti-Viral/Anti-Inflammatory Drug Study Against COVID-19 Begins
RedHill Biopharma has initiated a global phase 2/3 study in order to evaluate the use of opaganib in patients with severe COVID-19.
Herman Cain Passes After 3-Week Coronavirus Battle
On Tuesday, Cain was said to be recovering, possibly reflecting the complex immune system stages of COVID-19 disease course.
Coronavirus Science Is Not Binary
Why reducing pandemic research and response to yes-or-no outcomes is harming public health.
Webinar: Race for a COVID-19 Vaccine
MJH Life Sciences is presenting a webinar today on this important topic.
Early COVID-19 Cases Linked to China, Italy, Iran
People with travel links to China, Iran, and Italy may have accounted for nearly two-thirds of early COVID-19 cases in affected countries.
Quest: FDA Authorization Could Raise Daily Test Capacity by 35000
The method extracts SARS-CoV-2 RNA with the Mag-Bind Viral RNA Xpress Kit and the Hamilton MagEx STAR.
Connecting COVID-19 to Cancer Research
Dr. Adam Brufsky, an oncologist, compares viral and cancer immunity. Dr. Patrick Soon-Shiong connects the relation to COVID-19 vaccine research.
Setting Standards for a COVID-19 Vaccine
What should be anticipated in effectiveness and implication for the leading candidates.
RA Therapy Studied for COVID-19 Does Not Meet Endpoint
Roche’s tocilizumab did not improve clinical status in hospitalized adult patients with severe COVID-19 associated pneumonia.
Ebola Survivors Face Stigma, Reproductive Health Impact
Infectious disease specialists explain how long term international cooperation with impacted societies can help to stop the cycle of Ebola outbreaks.
Age-Related Comorbidities for Patients Living with HIV
Nearly half of all the people living with HIV are over the age of 50, so age-related comorbidities are becoming a factor.
Can We Fight Coronavirus Without a Vaccine? Explaining Monoclonal Antibody Research
What happens if we don't get a COVID-19 vaccine? Patrick Soon-Shiong, MD, describes another potential route for research efforts, which could also supplement vaccine development.
More Than Respiratory: Looking at How COVID-19 Affects Other Systems
One cardiologist speaks about what she witnessed in her NYC hospital including how the virus can be multi-organ and the development of COVID-19 diagnostic protocols.
Newborns Not at Increased Perinatal COVID-19 Risk
A cohort assessment of New York-based deliveries from SARS-CoV-2 positive mothers showed no infants were infected nor symptomatic after 2 weeks.
Delays in Covid-19 Testing and Tracing Affect Transmission Rate
A new modeling study reveals that transmission rates decline if people get their results early and quickly notify contacts of potential exposure.
Adenovirus COVID-19 Vaccines: Challenges of Prior AD Immunity
Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.
FDA Gives EUA for At-Home COVID-19 Testing
The federal agency gives approval for technology company’s test that supports unmonitored testing.
Can Moderna's COVID 19 Vaccine Generate Lasting Immunity?
Dr. Patrick Soon-Shiong, Chairman and CEO of ImmunityBio, explains why T-cell immunity could be an important metric when evaluating experimental COVID-19 vaccines.
Moderna, NIH Begin Phase 3 Trial for Their COVID-19 Vaccine
The randomized, placebo-controlled trial will be enrolling 30000 American adults to test the safety and efficacy of the codeveloped vaccine.
How Some COVID-19 Patients Lose Their Sense of Smell
Researchers have identified which olfactory cell types are vulnerable to the virus.
First COVID-19 Diagnostic Test Approved for Everyone
FDA reissues LabCorp’s existing diagnostic test for EUA, which opens up testing protocol for anyone.
ID Pipeline News: HHS Purchases Vaccine, FDA Approves Pooled COVID-19 Testing
A round up of the week's infectious disease pipeline developments.
Small Quantity of Sedative Dexmedetomidine Recalled Due to Cross-Contamination
Weekly, we identify FDA product and drug recalls which have the potential to be clinically relevant.
Strokes Linked to COVID-19 Appear More Dangerous
Stroke associated with SARS-CoV-2 infection appears to be more dangerous for patients relative to the baseline risk from stroke, according to a study published earlier this month.
Fauci on Going Back to School: It Depends on Where You Live
The NIAID director offered nuanced advice on kids going back to school, getting to a baseline in the US, and how to prepare for the upcoming influenza season combined with COVID-19.
Contagion Rapid Readout: A Clinical Review of Remdesivir for COVID-19
A discussion between providers on 3 studies related to the antiviral.
New CDC Guidelines Highlight School Reopenings in Europe, Asia
There is mixed international evidence about whether returning to school results in increased transmission or outbreaks, authors explained, and surges may be multiply determined.
